{"slug":"drugs-by-approvals","title":"Products by number of approval records","basis":"Approved products ordered by how many approval records they carry, one per regulator and indication.","metric":"Approval records","context":"First approval","how":"Counts entries in the approvals field of drug records with status approved. The same indication approved by two regulators counts twice; a label extension counts as its own record. The context column gives the earliest approval's regulator and year. Supportive care medicines (antiemetics, growth factors, epoetins, bone-modifying agents, antidotes, opioids for cancer pain, immunoglobulin; drug records flagged supportive) are not products or treatments here and are left out.","coverage":{"filled":443,"of":443,"what":"approved products carry at least one approval record","share":1},"total":443,"top":50,"rows":[{"rank":1,"id":"pembrolizumab","name":"Pembrolizumab","kind":"drug","route":"/drugs/pembrolizumab/","value":19,"metric":"19","context":"US 2014"},{"rank":2,"id":"atezolizumab","name":"Atezolizumab","kind":"drug","route":"/drugs/atezolizumab/","value":9,"metric":"9","context":"US 2016"},{"rank":3,"id":"durvalumab","name":"Durvalumab","kind":"drug","route":"/drugs/durvalumab/","value":9,"metric":"9","context":"US 2017"},{"rank":4,"id":"nivolumab","name":"Nivolumab","kind":"drug","route":"/drugs/nivolumab/","value":9,"metric":"9","context":"US 2014"},{"rank":5,"id":"olaparib","name":"Olaparib","kind":"drug","route":"/drugs/olaparib/","value":9,"metric":"9","context":"US 2014"},{"rank":6,"id":"bevacizumab","name":"Bevacizumab","kind":"drug","route":"/drugs/bevacizumab/","value":8,"metric":"8","context":"US 2004"},{"rank":7,"id":"osimertinib","name":"Osimertinib","kind":"drug","route":"/drugs/osimertinib/","value":8,"metric":"8","context":"US 2015"},{"rank":8,"id":"trastuzumab-deruxtecan","name":"Trastuzumab deruxtecan","kind":"drug","route":"/drugs/trastuzumab-deruxtecan/","value":8,"metric":"8","context":"US 2019"},{"rank":9,"id":"cabozantinib","name":"Cabozantinib","kind":"drug","route":"/drugs/cabozantinib/","value":7,"metric":"7","context":"US 2012"},{"rank":10,"id":"encorafenib","name":"Encorafenib","kind":"drug","route":"/drugs/encorafenib/","value":7,"metric":"7","context":"US 2018"},{"rank":11,"id":"sacituzumab-govitecan","name":"Sacituzumab govitecan","kind":"drug","route":"/drugs/sacituzumab-govitecan/","value":7,"metric":"7","context":"US 2020"},{"rank":12,"id":"amivantamab","name":"Amivantamab","kind":"drug","route":"/drugs/amivantamab/","value":6,"metric":"6","context":"US 2021"},{"rank":13,"id":"cetuximab","name":"Cetuximab","kind":"drug","route":"/drugs/cetuximab/","value":6,"metric":"6","context":"US 2004"},{"rank":14,"id":"crizotinib","name":"Crizotinib","kind":"drug","route":"/drugs/crizotinib/","value":6,"metric":"6","context":"US 2011"},{"rank":15,"id":"entrectinib","name":"Entrectinib","kind":"drug","route":"/drugs/entrectinib/","value":6,"metric":"6","context":"JP 2019"},{"rank":16,"id":"ivosidenib","name":"Ivosidenib","kind":"drug","route":"/drugs/ivosidenib/","value":6,"metric":"6","context":"US 2018"},{"rank":17,"id":"regorafenib","name":"Regorafenib","kind":"drug","route":"/drugs/regorafenib/","value":6,"metric":"6","context":"US 2012"},{"rank":18,"id":"selpercatinib","name":"Selpercatinib","kind":"drug","route":"/drugs/selpercatinib/","value":6,"metric":"6","context":"US 2020"},{"rank":19,"id":"trifluridine-tipiracil","name":"Trifluridine/tipiracil","kind":"drug","route":"/drugs/trifluridine-tipiracil/","value":6,"metric":"6","context":"US 2015"},{"rank":20,"id":"brigatinib","name":"Brigatinib","kind":"drug","route":"/drugs/brigatinib/","value":5,"metric":"5","context":"US 2017"},{"rank":21,"id":"datopotamab-deruxtecan","name":"Datopotamab deruxtecan","kind":"drug","route":"/drugs/datopotamab-deruxtecan/","value":5,"metric":"5","context":"US 2025"},{"rank":22,"id":"gemcitabine","name":"Gemcitabine","kind":"drug","route":"/drugs/gemcitabine/","value":5,"metric":"5","context":"US 1996"},{"rank":23,"id":"ibrutinib","name":"Ibrutinib","kind":"drug","route":"/drugs/ibrutinib/","value":5,"metric":"5","context":"US 2013"},{"rank":24,"id":"liposomal-irinotecan","name":"Liposomal irinotecan","kind":"drug","route":"/drugs/liposomal-irinotecan/","value":5,"metric":"5","context":"US 2015"},{"rank":25,"id":"panitumumab","name":"Panitumumab","kind":"drug","route":"/drugs/panitumumab/","value":5,"metric":"5","context":"US 2006"},{"rank":26,"id":"ruxolitinib","name":"Ruxolitinib","kind":"drug","route":"/drugs/ruxolitinib/","value":5,"metric":"5","context":"US 2011"},{"rank":27,"id":"sotorasib","name":"Sotorasib","kind":"drug","route":"/drugs/sotorasib/","value":5,"metric":"5","context":"US 2021"},{"rank":28,"id":"ziv-aflibercept","name":"Ziv-aflibercept","kind":"drug","route":"/drugs/ziv-aflibercept/","value":5,"metric":"5","context":"US 2012"},{"rank":29,"id":"adagrasib","name":"Adagrasib","kind":"drug","route":"/drugs/adagrasib/","value":4,"metric":"4","context":"US 2022"},{"rank":30,"id":"afatinib","name":"Afatinib","kind":"drug","route":"/drugs/afatinib/","value":4,"metric":"4","context":"US 2013"},{"rank":31,"id":"alectinib","name":"Alectinib","kind":"drug","route":"/drugs/alectinib/","value":4,"metric":"4","context":"US 2015"},{"rank":32,"id":"asparaginase","name":"Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase)","kind":"drug","route":"/drugs/asparaginase/","value":4,"metric":"4","context":"US 1994"},{"rank":33,"id":"belzutifan","name":"Belzutifan","kind":"drug","route":"/drugs/belzutifan/","value":4,"metric":"4","context":"US 2021"},{"rank":34,"id":"bracanalysis-cdx","name":"BRACAnalysis CDx","kind":"drug","route":"/drugs/bracanalysis-cdx/","value":4,"metric":"4","context":"US 2014"},{"rank":35,"id":"ceritinib","name":"Ceritinib","kind":"drug","route":"/drugs/ceritinib/","value":4,"metric":"4","context":"US 2014"},{"rank":36,"id":"dabrafenib-trametinib","name":"Dabrafenib + trametinib","kind":"drug","route":"/drugs/dabrafenib-trametinib/","value":4,"metric":"4","context":"US 2014"},{"rank":37,"id":"daratumumab","name":"Daratumumab","kind":"drug","route":"/drugs/daratumumab/","value":4,"metric":"4","context":"US 2015"},{"rank":38,"id":"enzalutamide","name":"Enzalutamide","kind":"drug","route":"/drugs/enzalutamide/","value":4,"metric":"4","context":"US 2012"},{"rank":39,"id":"erlotinib","name":"Erlotinib","kind":"drug","route":"/drugs/erlotinib/","value":4,"metric":"4","context":"US 2004"},{"rank":40,"id":"everolimus","name":"Everolimus","kind":"drug","route":"/drugs/everolimus/","value":4,"metric":"4","context":"US 2009"},{"rank":41,"id":"fruquintinib","name":"Fruquintinib","kind":"drug","route":"/drugs/fruquintinib/","value":4,"metric":"4","context":"China 2018"},{"rank":42,"id":"her2-testing-assays","name":"HER2 IHC and ISH companion assays (HercepTest, PATHWAY 4B5, HER2 Dual ISH)","kind":"drug","route":"/drugs/her2-testing-assays/","value":4,"metric":"4","context":"US 1998"},{"rank":43,"id":"larotrectinib","name":"Larotrectinib","kind":"drug","route":"/drugs/larotrectinib/","value":4,"metric":"4","context":"US 2018"},{"rank":44,"id":"lenalidomide","name":"Lenalidomide","kind":"drug","route":"/drugs/lenalidomide/","value":4,"metric":"4","context":"US 2005"},{"rank":45,"id":"lenvatinib","name":"Lenvatinib","kind":"drug","route":"/drugs/lenvatinib/","value":4,"metric":"4","context":"US 2015"},{"rank":46,"id":"lorlatinib","name":"Lorlatinib","kind":"drug","route":"/drugs/lorlatinib/","value":4,"metric":"4","context":"US 2018"},{"rank":47,"id":"luspatercept","name":"Luspatercept","kind":"drug","route":"/drugs/luspatercept/","value":4,"metric":"4","context":"US 2019"},{"rank":48,"id":"pluvicto","name":"Lutetium-177 vipivotide tetraxetan","kind":"drug","route":"/drugs/pluvicto/","value":4,"metric":"4","context":"US 2022"},{"rank":49,"id":"nab-paclitaxel","name":"Nab-paclitaxel","kind":"drug","route":"/drugs/nab-paclitaxel/","value":4,"metric":"4","context":"US 2005"},{"rank":50,"id":"oncomine-dx-target-test","name":"Oncomine Dx Target Test","kind":"drug","route":"/drugs/oncomine-dx-target-test/","value":4,"metric":"4","context":"US 2017"}]}